Reading the tape
NYSE: MOH
Molina Healthcare, Inc.
Healthcare · Medical - Healthcare Plans
Market Cap
$10.01B
52w High
$333.00
52w Low
$121.06
P/E
52.13
Volume
1.14M
Outstanding Shares
52.10M
Price vs Fundamentals
Why The Stock Is Moving
Likely fundamental deteriorationModerate confidence
1Y Price: -39.41%Revenue (TTM): 7.66%FCF (TTM): -52.19%P/FCF: 97th pct
What changed
The stock fell 39.41% over the last year. Revenue grew 7.66% over the trailing twelve months. Operating margin moved from 4.09% to 1.16%. Free cash flow declined 52.19% over the trailing twelve months.
What the market seems to be pricing
The market is reacting to weaker business momentum more than just compressing the valuation multiple. Even if the shares already screen cheap on P/FCF, investors are still discounting lower future earnings power.
What would invalidate this read
Operating margin stands at 1.16%. Free cash flow fell 52.19% — a return toward positive territory would undermine the deterioration thesis. If margins and cash flow stabilize while the stock stays depressed, the gap shifts from fundamental damage toward pure multiple compression.
Company profile
Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.
CEOJoseph Michael Zubretsky
SectorHealthcare
IndustryMedical - Healthcare Plans
Employees18,000
IPO dateJul 2, 2003
Valuation
Forward P/E—
EV/EBITDA8.73
Enterprise value$8.52B
Price / Book2.46
Stock splits
May 23, 2011↑ Forward
Every 2 shares became 3
Profitability & growth
Standard profitability metrics can be misleading for financial/insurance companies. GAAP requires unrealized investment gains/losses in net income (affecting ROE), and margins are blended across diverse business segments.
Revenue growth-3.15%
Gross margin9.59%▼23.00%vs FY2024
Operating margin1.16%▼59.06%vs FY2024
ROE11.6%▼55.76%vs FY2024
Analyst consensus
RatingBuy
Target price$166.09▼13.57%
17
Buy
15
Hold
6
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Jul 22, 2026
Q3 FY26 · EPS est $1.45 · Revenue est $10.84B
View